N-nitrosoproline excretion in the presence and absence of gastric disease. 1991

T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
Imperial Cancer Research Fund, Radcliffe Infirmary, Oxford, UK.

N-nitrosoproline (NPRO) excretion, an indicator of endogenous nitrosation, was measured in a group of hospital inpatients who were identified by endoscopy and gastric biopsy as either having gastric lesions or having healthy stomachs. NPRO was assayed in background 24-hour urine samples and samples collected after loading doses of nitrate and L-proline. The presence of gastric lesions was associated with altered gastric pH and concomitant changes in gastric juice nitrate and nitrite concentration. Gastric juice pH increased with increasing severity of gastric disease (P = 0.031) and patients with normal stomachs had a lower gastric pH than those with chronic atrophic gastritis (CAG) (3.0 vs. 6.5, P = 0.017). The changes in gastric juice nitrate concentration were in the reverse direction (P = 0.002 for trend) with normal patients having higher mean levels than CAG patients (12.7 vs. 5.5 micrograms/ml, P less than 0.0001). Nitrite concentration increased with severity of gastric disease but the results were not significant (normal, 82.9 vs. CAG, 223.4 ng/ml, P = 0.069). No association was found between the presence of gastric lesions and increased urinary NPRO excretion. Mutagenic activity was not detected in any of the gastric juice samples.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005750 Gastric Juice The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651) Gastric Juices,Juice, Gastric,Juices, Gastric
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D005757 Gastritis, Atrophic GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis. Atrophic Gastritides,Atrophic Gastritis,Gastritides, Atrophic

Related Publications

T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
January 1984, IARC scientific publications,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
August 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
February 1987, Gut,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
January 1987, IARC scientific publications,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
May 1978, IARC monographs on the evaluation of the carcinogenic risk of chemicals to man,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
January 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
January 1987, IARC scientific publications,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
January 1984, IARC scientific publications,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
January 1975, Toxicology,
T M Knight, and S Leach, and D Forman, and C Vindigni, and P Packer, and S Venitt, and C Minacci, and L Lorenzini, and P Tosi, and G Frosini
April 1985, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Copied contents to your clipboard!